Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SIMCERE PHARMA (HK.2096) to host 2022 R&D Day 2022-04-07 21:39
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer 2022-02-24 13:34
Simcere Pharma (2096.HK) Announces a Positive Profit Alert 2022-02-23 16:22
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments 2021-11-23 11:22
1 2